Amplification of CD20 Cross-Linking in Rituximab-Resistant BLymphoma Cells Enhances Apoptosis Induction by Drug-Free Macromolecular Therapeutics

doi 10.1021/acsnano.8b00797.s001
Full Text
Abstract

Available in full text

Date

Unknown

Authors

Unknown

Publisher

American Chemical Society (ACS)

Related search

Drug-Free Macromolecular Therapeutics: Induction of Apoptosis by Coiled-Coil-Mediated Cross-Linking of Antigens on the Cell Surface

Angewandte Chemie
2010English

Transglutaminase 2 Contributes to Apoptosis Induction in Jurkat T Cells by Modulating Ca2+ Homeostasis via Cross-Linking RAP1GDS1

PLoS ONE
Multidisciplinary
2013English

CD20 Antibody (C2b8)-Induced Apoptosis of Lymphoma Cells Promotes Phagocytosis by Dendritic Cells and Cross-Priming of CD8+ Cytotoxic T Cells

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2001English

Regulation of CD20 in Rituximab-Resistant Cell Lines and B-Cell Non-Hodgkin Lymphoma

Clinical Cancer Research
Cancer ResearchOncology
2012English

Induction of Interleukin-6 Production by Rituximab in Human B Cells

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2014English

Rituximab in CD20 Positive Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

Proteasome Inhibitor PS-341 Induces Apoptosis in Cisplatin-Resistant Squamous Cell Carcinoma Cells by Induction of Noxa

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

Two Structurally Different Rituximab-Specific CD20 Mimotope Peptides Reveal That Rituximab Recognizes Two Different CD20-Associated Epitopes

Journal of Immunology
AllergyImmunology
2008English

Cross-Linking of LFA-1 Molecule Enhances Fas Mediated Apoptosis of Jurkat and Burkitt Lymphoma Cell Lines

Cell Death and Differentiation
Cell BiologyMolecular Biology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy